Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs placebo in Japanese adults with early rheumatoid arthritis
jRCT2080220724Phase 3
- Sponsor
- Abbott Laboratories
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Adalimumab with Placebo (2 arms).
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080220724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220724.